Cmax Biotech Consulting SRL
Cmax Biotech Consulting reported total assets of 52,078 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Cmax Biotech Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -85 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cmax Biotech Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 21 Mar 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
Cmax Biotech Consulting's financial analysis
- Solvency10.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cmax Biotech Consulting
Cmax Biotech Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.922.317
- VAT number
- BE0784922317
- Peppol
- Registered · 0208:0784922317 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Apr 2022
- Registered office
- 3511 Hasselt
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Cmax Biotech Consulting (SRL) has been based in Hasselt since 2022, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 12,278 € and equity of 5,646 €; its revenue is not published. Its solvency stands at 10.8%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cmax Biotech Consulting
Companies in the same business, of comparable size and area, outside its group.
- Emelie Flemming-Parker Research and experimental development on natural sciences and engineering Tongeren-Borgloon · balance sheet 114,901 €
- Immunofusion Research and experimental development on natural sciences and engineering Charleroi · balance sheet 32,131 €
- Artlinow Research and experimental development on natural sciences and engineering Lasne · balance sheet 156,662 €
- ResiResearch Research and experimental development on natural sciences and engineering Anderlecht · balance sheet 165,690 €
- Arhea Research and experimental development on natural sciences and engineering Tongeren-Borgloon · balance sheet 171,716 €
- 1889 Consulting Research and experimental development on natural sciences and engineering Forest · balance sheet 42,356 €
- VKJ-Engineering Research and experimental development on natural sciences and engineering Heist-op-den-Berg · balance sheet 41,764 €
- BSS-Consult All other professional, scientific and technical activities n.e.c. Moorslede · balance sheet 88,104 €
Frequently asked questions about Cmax Biotech Consulting
What is the revenue of Cmax Biotech Consulting?
Cmax Biotech Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cmax Biotech Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0784922317 for Cmax Biotech Consulting, if the company is VAT-registered. Its company number (CBE) is 0784.922.317.
Where is the registered office of Cmax Biotech Consulting?
According to the CBE register, the registered office of Cmax Biotech Consulting is in 3511 Hasselt.
What is the equity of Cmax Biotech Consulting?
At the close of the 2025 financial year, the equity of Cmax Biotech Consulting amounts to 5,646 €, a solvency of 10.8% of total assets.
Who manages Cmax Biotech Consulting?
The register lists 1 active mandates at Cmax Biotech Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cmax Biotech Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →